TRVI
Trevi Therapeutics Inc
14.40$
-1.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +8.6% | -5.3% | +5.6% | -2.6% | +2.7% | +0.0% | -18.4% | +9.7% | +0.0% | – | |
| – | +0.8% | +35.4% | +55.9% | -27.2% | +11.7% | +31.7% | +14.6% | -10.2% | +8.6% | +62.3% | +49.3% | – | |
| – | +255.6% | -108.4% | – | +15.6% | -68.0% | -506.2% | – | -116.1% | – | – | – | – | |
| – | +22.2% | -100.0% | – | -100.0% | – | +192,428.6% | -100.0% | – | +112,208.3% | -99.2% | +21.6% | – | |
| – | -28.6% | -163.0% | – | +177.0% | -411.4% | -58.3% | -73.8% | +1,851.6% | -39.9% | – | -760.4% | – | |
| – | – | – | – | – | -3.1% | -64.5% | -100.0% | – | – | – | – | – | |
| – | -103.6% | -48.1% | – | -1.8% | +933.9% | -83.1% | +1,168.2% | -98.5% | -82.6% | -21.8% | +73,934.7% | – | |
| – | -47.3% | -389.0% | – | – | +484.2% | -181.6% | – | -161.6% | – | – | +6,906.0% | – | |
| – | – | – | – | – | – | – | – | – | – | -387.2% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.